Journal of Academy of Medical Sciences
Home | About the journal | Editorial board | Search | Ahead of print | Current issue | Archives
Subscribe | Submit article | Instructions | Subscribe | Contact us | Login 
 
  Users Online: 85 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
ORIGINAL ARTICLE
Year : 2012  |  Volume : 2  |  Issue : 2  |  Page : 57-63

Platelet aggregation in children with end-stage kidney disease in relation to level of L-arginine as a risk factor for vascular thrombosis


1 Faculty of Medicine, Zagazig University, Sharkeya, Egypt
2 Department of Clinical Pathology, Faculty of Medicine, Zagazig University, Sharkeya, Egypt
3 Department of Biochemistry, Faculty of Medicine, Zagazig University, Sharkeya, Egypt

Correspondence Address:
Doaa Youssef
Department of Pediatrics, Zagazig University, Sharkeya
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2249-4855.118660

Rights and Permissions

Background: L-arginine is the precursor for nitric oxide (NO) synthesis in vascular cells. The sources of L-arginine are endogenous and exogenous. Although macrophages and endothelial cells can generate L-arginine, most synthesis takes place in the liver and kidney. Level of L-arginine as of other amino acids is affected in malnourished patients; NO regulates platelet activation by inhibiting adhesion and aggregation. Objectives: The aim of the study is to evaluate the level of L-arginine in patients of end-stage kidney disease (ESKD) under regular hemodialysis and to determine its relation to platelet aggregation as a risk factor for vascular thrombosis which is a very important complication that affects the life span of those patients. In addition, we also tried to establish the relationship between L-arginine, platelet aggregation, and nutritional state of patients with ESKD. Subjects and Methods: Our study was "a case-control study", comparing data between 30 patients with ESKD under treatment with regular hemodialysis-group (A); group A1 (16)-patients with ESKD on regular hemodialysis with malnutrition, group A2 (14)-patients with ESKD on regular hemodialysis with normal nutrition state, and group B 10 subjects as healthy control group, each patient was evaluated for serum arginine level by high-performance liquid chromatography, and platelet aggregation, as well as other routine investigations. A thorough clinical history and examination were performed for all the patients. Results: Our study shows significant higher level of platelet aggregation to ADP in group A than group B (119±11.9% and 81.1±6.5% respectively, P < 0.05), a lower level of serum arginine in group A (71±45.3 μg/L) than in group B (120.5±14.6 μg/L) with P< 0.05. Also our study shows a lower level of serum arginine in group A1 (60.5±12.3 μg/L) than group A2 (83±27 μg/L) and a lower level in group A2 than group B (120.5±14.6 μg//l), and we found a negative correlation between serum arginine level and platelet aggregation expressing a more risk for thrombosis in patients with ESKD specially those with malnutrition. Conclusions: We concluded that patients with ESKD has a low level of L-arginine specially in those with malnutrition and this leads to increase in platelet aggregation and may increase the possibility of thrombus formation in malnourished patients with ESKD. We suggest the use of nutritional supplementation of L-arginine to suppress this process of atherothrombosis.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3100    
    Printed188    
    Emailed0    
    PDF Downloaded246    
    Comments [Add]    

Recommend this journal